Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PRIVIA HEALTH GROUP, INC.

(PRVA)
  Report
Real-time Estimate Quote. Real-time Estimate Cboe BZX - 12/06 01:49:46 pm
21.445 USD   +1.44%
11/29INSIDER SELL : Privia Health Group
MT
11/26INSIDER SELL : Privia Health Group
MT
11/24PRIVIA HEALTH : PRVA Investor Presentation - November 2021
PU
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news

Privia Health : to Report Third Quarter 2021 Results on Monday, November 8

10/07/2021 | 09:01am EST

ARLINGTON, Va., Oct. 07, 2021 (GLOBE NEWSWIRE) -- Privia Health Group, Inc. (Nasdaq: PRVA) today announced that it plans to release financial results for the third quarter ended September 30, 2021 before market open on Monday, November 8, 2021.

The press release is expected to be publicly disseminated by 7:00 am ET / 6:00 am CT and will also be available on the Company’s Investor Relations website at ir.priviahealth.com. Privia Health management will host a conference call beginning at 8:00 am ET / 7:00 am CT on the same day, Monday, November 8th, to discuss the results and management’s outlook for future financial and operational performance. The conference call can be accessed via webcast at ir.priviahealth.com/news-and-events/events-and-presentations or by dialing 855-940-5315 (929-517-0419 for international participants), and referencing participant code 4491575.

The webcast will be archived and available for replay for on-demand listening shortly after the completion of the call at ir.priviahealth.com/news-and-events/events-and-presentations.

About Privia Health

Privia Health™ is a technology-driven, national physician enablement company that collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual settings. Our platform is led by top industry talent and exceptional physician leadership, and consists of scalable operations and end-to-end, cloud-based technology that reduces unnecessary healthcare costs, achieves better outcomes, and improves the health of patients and the well-being of providers. For more information, visit priviahealth.com.

Contact
Robert Borchert
SVP, Investor & Corporate Communications
IR@priviahealth.com
817.783.4841


Primary Logo

Source: Privia Health Group, Inc.

2021 GlobeNewswire, Inc., source Press Releases

All news about PRIVIA HEALTH GROUP, INC.
11/29INSIDER SELL : Privia Health Group
MT
11/26INSIDER SELL : Privia Health Group
MT
11/24PRIVIA HEALTH : PRVA Investor Presentation - November 2021
PU
11/19Privia Health Group Prices Secondary Common Stock Offering at $29 Per Share
MT
11/18Privia Health Announces Pricing of Secondary Offering
GL
11/16Privia Health Sinking in Late Trade After Launching Secondary Offering of 6 Million Sha..
MT
11/16Privia Health Announces Secondary Offering
GL
11/15PRIVIA HEALTH : Named in Inc.'s First-Annual Best-Led Companies List
PU
11/09SVB Leerink Adjusts Price Target on Privia Health Group to $42 from $35, Keeps Outperfo..
MT
11/08PRIVIA HEALTH GROUP, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ..
AQ
More news
Analyst Recommendations on PRIVIA HEALTH GROUP, INC.
More recommendations
Financials (USD)
Sales 2021 918 M - -
Net income 2021 -157 M - -
Net cash 2021 302 M - -
P/E ratio 2021 -13,6x
Yield 2021 -
Capitalization 2 251 M 2 251 M -
EV / Sales 2021 2,12x
EV / Sales 2022 1,87x
Nbr of Employees 559
Free-Float 84,2%
Chart PRIVIA HEALTH GROUP, INC.
Duration : Period :
Privia Health Group, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PRIVIA HEALTH GROUP, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 21,14 $
Average target price 44,00 $
Spread / Average Target 108%
EPS Revisions
Managers and Directors
Matthew Shawn Morris Chief Executive Officer & Director
Parth Mehrotra President & Chief Operating Officer
David Mountcastle Chief Financial Officer
David P. King Chairman
Keith Fernandez Chief Clinical Officer